Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2013

Jun 27, 2013

6990_rns_2013-06-28_07cf3997-1874-4b25-ac69-848461bebbf2.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

☐ Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden hours per response 0.5
1. Name and Address of Reporting Person*
Aberman Zami 0001344740
PLURISTEM THERAPEUTICS
INC [PSTI] 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
☑ Director 10% Owner
☑ Officer (give title below)
CEO & Chairman
--- ---
(Last) (First)
46 HATAPUZ ST.
06/27/2013
(Street)
(Month/Day/Year) 6. Individual or Joint/Group Filing (Check
Applicable Line)
☑ Form filed by One Reporting Person
Form filed by More than One Reporting
Person
TELMOND L3
(City) (State)
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
--- ---
1. Title of Security (Instr. 3) 2. Transaction Date
(Month/Day/Year) 2A. Deemed Execution Date, if any
(Month/Day/Year) 3. Transaction Code (Instr. 8)
Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
Common Stock 06/27/2013(1)
Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
--- ---
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security
(Month/Day/Year) 3A. Deemed Execution Date, if any
(Month/Day/Year) 4. Transaction Code (Instr. 8)
(Month/Day/Year)

Explanation of Responses:

  1. The shares vest as follows: 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3 months thereafter.

Remarks:

/s/ Zami Aberman

06/27/2013

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.